-
Colorectal cancer survivor diagnosed at 40 showed almost no symptoms – except this one
“We evolved over time to include bacteria in our mouths and our GI tracts. Think of it as your own personal soil,” Dr. John L. Marshall said. “So, our leading theory is: Just like we’re changing our air and we’re changing our water with the world around us, we are probably also changing the world inside of us, our own microbiome.”
Category: News
-
FDA Approves First Blood Test Screening for CRC
“This is a new way to test for if you have an early cancer or an early polyp in the colon that doesn’t involve your poop, that doesn’t involve a bowel prep,” John Marshall, MD said. “So for a lot of people, this means you’ve got no more excuse not to get screening for colon cancer.”
Category: News
-
ctDNA Testing Could Lead to New Ways of Staging Cancer Patients
ctDNA, or circulating tumor DNA, is now used as a biomarker in new testing to detect cancer—or its absence —in a patient’s blood. Dr. Weinberg discusses his research.
Category: News
-
Overview of Molecular Testing and Barriers in mCRC
Evolving Treatments of Metastatic CRC: Insights from ASCO 2024. Dr. Marshall gives an overview of mMolecular testing and barriers in mCRC
Category: News
-
Colorectal Cancer Cases Tripled in Teens
The overall shift of these cancers being seen in younger people and evidence of “a trend that did not stop with the 20-year-olds,”Dr. John L. Marshall says.
Category: News
-
National Cancer Institute Renews Georgetown Lombardi Top Designation
The National Cancer Institute (NCI), a part of the National Institutes of Health, has awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown University‘s Lombardi Comprehensive Cancer Center in recognition of its high-impact research, community outreach and cancer care
Category: News
-
Dr. John Marshall Inducted into Giants of Cancer Care
This program honors and celebrates the accomplishments of leading researchers and educators whose discoveries have propelled the field and set the groundwork for future advancements.
Category: News
-
Treating Colorectal Cancer: Overview of MRD Testing and ctDNA
Dr. Marshall and Dr. Weinberg and other oncologists, provide an overview of circulating tumor DNA and its role in MRD (minimal residual disease) testing in the treatment of patients with colorectal cancer.
Category: News
-
Fight CRC Raises Colorectal Cancer Awareness on National Mall
To celebrate National Colorectal Cancer Awareness Month, volunteers for the advocacy organization Fight CRC planted 27,400 flags across the National Mall to raise awareness about early-onset colorectal cancer rates Mar. 9.
Category: News
-
Molecular Profiling Improves Outcomes in Biliary Tract Cancer
Research by Dr. Aiwu Ruth He shows patients with biliary cancer who undergo molecular profiling appear to survive significantly longer when compared with those who do not.
Category: News